Emerging Methods in Comparative Effectiveness and Safety: Symposium Overview and Summary

@article{Lohr2007EmergingMI,
  title={Emerging Methods in Comparative Effectiveness and Safety: Symposium Overview and Summary},
  author={Kathleen N. Lohr},
  journal={Medical Care},
  year={2007},
  volume={45},
  pages={S5-S8}
}
  • K. Lohr
  • Published 1 October 2007
  • Medicine
  • Medical Care
Background:Interest in new methods for comparative effectiveness, drug and patient safety, and related studies is burgeoning. The advent of Medicare Part D for outpatient prescription drugs has drawn significant attention to the need for efficient ways to monitor the potential benefits and harms of pharmaceuticals. These trends prompted the Effective Health Care program at the Agency for Healthcare Research and Quality and its DEcIDE (Developing Evidence to Inform Decisions about Effectiveness… 
Assessing Harms When Comparing Medical Interventions
TLDR
This Guide presents issues key to the development of Comparative Effectiveness Reviews and describes recommended approaches for addressing difficult, frequently encountered methodological issues and will be updated as further empiric evidence develops and the understanding of better methods improves.
An overview of methods for comparative effectiveness research.
Assessing harms when comparing medical interventions: AHRQ and the Effective Health-Care Program
TLDR
Suggestions for prioritizing harms to be evaluated, use of terminology related to reporting of harms, selection of sources of evidence on harms, and assessment of risk of bias (quality) of harms reporting are included.
Standards, Practices, and Methods for the Use of Administrative Claims Data
TLDR
A set of standards and practices for researchers to follow is proposed for the acquisition and proper use of administrative data to help researchers use administrative data correctly so that policy makers can have greater confidence in findings, and research can have a greater effect on public policy.
Comparative effectiveness research: guidelines for good practices are just the beginning
TLDR
The structure, process and outcomes of that task force, comment on the potential impact of the report in the context of comparative effectiveness research, and offer a few observations on the future of this field are examined.
Building reliable evidence from real-world data: methods, cautiousness and recommendations
TLDR
The aim is to provide researchers with a methodological framework, while commenting on the value of new techniques for more advanced users, and approaches to managing analytic challenges.
The CRACK programme: a scientific alliance for bridging healthcare research and public health policies in Italy
TLDR
The CRACK programme was based on their intention to remove barriers that thwart the process of bridging methods and findings from scientific journals to public health practice, and why it might find articulated application in Italy is discussed.
Benchmarking to improve the quality of cystic fibrosis care
  • M. Schechter
  • Medicine
    Current opinion in pulmonary medicine
  • 2012
TLDR
This review summarizes reports of how benchmarking has been operationalized in attempts to improve CF care, providing a pragmatic alternative to traditional research methods such as randomized controlled trials.
...
1
2
3
4
...

References

SHOWING 1-10 OF 31 REFERENCES
Practice-Based Evidence Study Design for Comparative Effectiveness Research
TLDR
Outcomes improved when practices associated with better outcomes in PBE-CPI analyses were adopted in practice and can uncover better practices more quickly than randomized controlled trials or sophisticated statistical methods, while achieving many of the same advantages.
Creating and Synthesizing Evidence With Decision Makers in Mind: Integrating Evidence From Clinical Trials and Other Study Designs
TLDR
The traditional evidence hierarchy, whereby evidence progresses linearly from basic research to rigorous RCTs, is revised, recognizing that other research designs can provide important evidence to strengthen the understanding of how to apply research findings in practice.
Design of Cluster-Randomized Trials of Quality Improvement Interventions Aimed at Medical Care Providers
TLDR
Challenges to compliance, expected small effects, and covariate imbalances are particularly likely in cluster-randomized trials of quality improvement interventions, when such trials are embedded in medical systems with available automated records, use of these data can enhance the design of the trial.
Studying Prescription Drug Use and Outcomes With Medicaid Claims Data: Strengths, Limitations, and Strategies
TLDR
Policy implications are discussed, including the potential for the research use of Medicare Part D data and the need for further initiatives to systematically develop and optimally use research datasets that link Medicaid and other sources of clinical and outcome information.
Designed Delays Versus Rigorous Pragmatic Trials: Lower Carat Gold Standards Can Produce Relevant Drug Evaluations
TLDR
A 2-stage qualitative reassessment of designed delays (DD) trials of a cost-saving nebulizer-to-inhaler conversion policy and a proposed DD trial of reduced restrictions on Cox-2 inhibitors found that DD trials can be negotiated with policymakers.
Adjustments for Unmeasured Confounders in Pharmacoepidemiologic Database Studies Using External Information
TLDR
Using an external validation study without data on disease outcome to adjust for unmeasured confounding, propensity score calibration (PSC) leads to a plausible estimate of the association between NSAIDs and mortality in the elderly, if the biases caused by measured and unme measured confounders go in the same direction.
Increasing Levels of Restriction in Pharmacoepidemiologic Database Studies of Elderly and Comparison With Randomized Trial Results
TLDR
In this example of a large database study, restricting to incident drug users, similar comparison groups, patients without contraindication, and to adherent patients was a practical strategy, which limited the effect of confounding, as these approaches yield results closer to those seen in RCTs.
Evaluating the Validity of an Instrumental Variable Study of Neuroleptics: Can Between-Physician Differences in Prescribing Patterns Be Used to Estimate Treatment Effects?
TLDR
The previous APM prescription written by the physician was unassociated with major medical comorbidities in the current patient, suggesting that the IV estimates were not biased by case-mix differences between physicians, and illustrates how internal validation approaches may be used to improve the design of quasi-experimental studies.
Improving Depiction of Benefits and Harms: Analyses of Studies of Well-Known Therapeutics and Review of High-Impact Medical Journals
TLDR
It is concluded that consistently depicting benefit and harm information in frequencies can substantially improve the communication of benefits and harms.
Using Propensity Scores Subclassification to Estimate Effects of Longitudinal Treatments: An Example Using a New Diabetes Medication
TLDR
A method of estimating effects of longitudinal treatments that uses subclassification on a longitudinal propensity score to compare outcomes between a new drug (exenatide) and established drugs (insulin and oral medications) assuming knowledge of the variables influencing the treatment assignment.
...
1
2
3
4
...